How closely does rheumatology treatment follow the guidelines? ambition and reality;Wie leitliniengerecht ist die rheumatologische versorgung? anspruch und wirklichkeit

Zeitschrift fur Rheumatologie

Volumn 69, Issue 4, 2010, Pages 318-326

  Zink, A ^a,b   Huscher, D ^a   Schneider, M ^c  

^a Forschungsbereich Epidemiologie   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

DMARD; Early treatment; Health care research; National database; Rheumatoid arthritis

Indexed keywords

GLUCOCORTICOID; METHOTREXATE;

HEALTH CARE; HUMAN; MEDICAL PROFESSION; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; RHEUMATOID ARTHRITIS; ARTHRITIS, RHEUMATOID; GERMANY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; INCIDENCE; REGISTER; RHEUMATOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA;

ARTHRITIS, RHEUMATOID; DELIVERY OF HEALTH CARE; GERMANY; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; INCIDENCE; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; REGISTRIES; RHEUMATOLOGY;

EID: 77955571566     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-009-0522-7     Document Type: Review

References (19)

1. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines (1996) Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 39:713-722
2. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 46 (2):328-346
3. Saag KG, Teng GG, Patkar NM et al (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59 (6):762-784
4. Schneider M, Lelgemann M, Abholz HH et al (2007) Interdisziplinäre Leitlinie Management der frühen rheumatoiden Arthritis. DGRh-Leitlinie, 2. überarbeitete Aufl. Steinkopff, Darmstadt
5. Quinn MA, Emery P (2003) Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 21 (5 Suppl 31): S154-S157
6. Nell VP, Machold KP, Eberl G et al (2004) Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43 (7):906-914
7. Goronzy JJ, Weyand CM (2009) Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther 11 (5):249
8. Goekoop-Ruiterman YP, Vries-Bouwstra JK, Allaart CF et al (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52 (11):3381-3390
9. Bakker MF, Jacobs JW, Verstappen SM, Bijlsma JW (2007) Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility. Ann Rheum Dis 66 (Suppl 3): iii56-iii60
10. Klarenbeek NB, Allaart CF, Kerstens PJ et al (2009) The BeSt story: on strategy trials in rheumatoid arthritis. Curr Opin Rheumatol 21 (3):291-298
11. Kommission Versorgung der Deutschen Gesellschaft für Rheumatologie (2008) Memorandum rheumatologische Versorgung von akut und chronisch Rheumakranken in Deutschland. http://www.dgrh.de/Versorgung
12. Westhoff G, Edelmann E, Zink A (2009) Das Zuweiser-Projekt. Symptomdauer bis zur Erstvorstellung beim internistischen Rheumatologen. Rheuma-Management 1 (2):13-15
13. Westhoff G, Edelmann E, Kekow J et al (2009) Symptomdauer bis zur rheumatologischen Erstvorstellung nach Diagnosen, Spezialisierung der Zuweiser und durchschnittlicher Wartezeit der Rheumatologen. 37. Kongress der Deutschen Gesellschaft für Rheumatologie, Köln. Z Rheumatol 68 (Suppl 1):35
14. Strangfeld A, Zink A (2006) Ambulante Betreuung von Patienten mit rheumatoider Arthritis durch Hausärzte oder Rheumatologen - Vergleich von Prozessen und Ergebnissen der Versorgung. In: Hey M, Maschewsky-Schneider U (Hrsg) Kursbuch Versorgungsforschung. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin, S 141-152
15. Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364 (9430):263-269
16. Schipper LG, Vermeer M, Kuper IH et al (2009) Tight control aiming at DAS28 remission is more effective in reaching high remission rates than usual care in rheumatoid arthritis. Arthritis Rheum 60 (Suppl 10): S605
17. Westhoff G, Schneider M, Raspe H et al (2009) Advance and unmet need of health care for patients with rheumatoid arthritis in the German population - results from the German Rheumatoid Arthritis Population Survey (GRAPS). Rheumatology (Oxford) 48 (6):650-657
18. Riemsma RP, Taal E, Kirwan JR, Rasker JJ (2004) Systematic review of rheumatoid arthritis patient education. Arthritis Rheum 51 (6):1045-1059
19. Duke SA, Colagiuri S, Colagiuri R (2009) Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev:CD005268